Clene (FRA:84C0) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:84C0 Clene Inc FRA:84C0
38 GF Score
Price €5.30
GF Value €0.74
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clene FFO?

FFO (Funds from operations) only applies to REITs.

FRA:84C0
38GF Score
Clene Inc FRA:84C0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clene (FRA:84C0) Overvalued in 2026?

Based on GuruFocus' analysis, Clene stock appears to be overvalued. The current stock price of €5.30 is trading 616.2% above its estimated GF Value™ of €0.74. GuruFocus considers Clene to be Significantly Overvalued.

Key valuation signals for FRA:84C0:

  • FFO:
  • GF Value™: €0.74 vs. price of €5.30 (616.2% above fair value)
  • GF Score™: 38/100 with 9 warning signs

No single metric tells the full story. See the FRA:84C0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clene Business Description

Other Exchanges CLNN:USA
Address 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
38GF Score

Get the complete analysis for FRA:84C0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.30
Price
€0.74
GF Value